Skip to main content

Kurdistan Regional Government in Iraq receives AstraZeneca vaccine

Some countries have suspended the British-Swedish vaccine due to its association with blood clots, though the European Union still recommends its use. The KRG previously received a small amount of Chinese vaccine doses.
Covid testing in Sulaimaniyah

The Kurdistan Regional Government (KRG) in Iraq has obtained tens of thousands more COVID-19 vaccine doses. 

KRG Prime Minister Masrour Barzani announced Friday that 43,800 doses of the AstraZeneca coronavirus vaccine have arrived in the autonomous part of northern Iraq. 

The KRG began administering vaccine doses in March to health care workers after receiving 5,000 doses of China’s Sinopharm vaccine.

AstraZeneca is a British-Swedish pharmaceutical company. Some countries have suspended administering the AstraZeneca vaccine recently due to reports of it being linked to blood clots. However, the latest findings from the European Union say that blood clotting arising from taking the vaccine is “very rare” and that its benefits vis-a-vis the virus outweigh the potential side effects. 

The State of Palestine has also received AstraZeneca vaccines.

The Kurdistan Region is reporting several hundred new virus infections a day, according to KRG statistics. There are still some capacity restrictions and closures in effect in the region. More than 6 million people live in the KRG’s territory. 

Join hundreds of Middle East professionals with Al-Monitor PRO.

Business and policy professionals use PRO to monitor the regional economy and improve their reports, memos and presentations. Try it for free and cancel anytime.

Free

The Middle East's Best Newsletters

Join over 50,000 readers who access our journalists dedicated newsletters, covering the top political, security, business and tech issues across the region each week.
Delivered straight to your inbox.

Free

What's included:
Our Expertise

Free newsletters available:

  • The Takeaway & Week in Review
  • Middle East Minute (AM)
  • Daily Briefing (PM)
  • Business & Tech Briefing
  • Security Briefing
  • Gulf Briefing
  • Israel Briefing
  • Palestine Briefing
  • Turkey Briefing
  • Iraq Briefing
Expert

Premium Membership

Join the Middle East's most notable experts for premium memos, trend reports, live video Q&A, and intimate in-person events, each detailing exclusive insights on business and geopolitical trends shaping the region.

$25.00 / month
billed annually

Become Member Start with 1-week free trial

We also offer team plans. Please send an email to pro.support@al-monitor.com and we'll onboard your team.

What's included:
Our Expertise AI-driven

Memos - premium analytical writing: actionable insights on markets and geopolitics.

Live Video Q&A - Hear from our top journalists and regional experts.

Special Events - Intimate in-person events with business & political VIPs.

Trend Reports - Deep dive analysis on market updates.

All premium Industry Newsletters - Monitor the Middle East's most important industries. Prioritize your target industries for weekly review:

  • Capital Markets & Private Equity
  • Venture Capital & Startups
  • Green Energy
  • Supply Chain
  • Sustainable Development
  • Leading Edge Technology
  • Oil & Gas
  • Real Estate & Construction
  • Banking

Start your PRO membership today.

Join the Middle East's top business and policy professionals to access exclusive PRO insights today.

Join Al-Monitor PRO Start with 1-week free trial